What You Should Know:
- Apstar Pharma acquires the assets of respiratory health company Cohero Health to expands its digital portfolio with a focus on respiratory disease management.
- Cohero Health develops digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization.
AptarGroup, Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions, and services, announces that it has acquired all operating
Read More
Cohero Health
Cohero Health Adds Strategic Investors Samsung NEXT, Omron Health to Support Commercialization of BreatheSmart
Cohero Health, a NYC-based digital health company developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, has added strategic investors Samsung NEXT and Omron Healthcare to its oversubscribed Series A round. The company originally announced its $9M Series A in late 2016 but elected to allow forthe investment of additional strategic capital. With the addition of the two new strategic investors/partners, the Series A round
Read More
Cohero Health Raises $9M to Expand Connected Respiratory Disease Solutions
Cohero Health, a NYC-based digital health company developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, has raised $9 million in Series A funding. The funding round is led by Three Leaf Ventures, an affiliate of the Broe Group, with continuing participation from Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts, and BioAdvance. To date, the company has raised $11 million in total
Read More
Cohero Health, Presspart Group Announces Commercialization of Connected Metered Dose Inhaler
Cohero Health, an NYC-based digital health company focused on developing connected health tools and technologies to improve respiratory care and Presspart Group, a specialist medical device and pharmaceutical component manufacturer, has announced the completion of their connected metered dose inhaler (eMDI). eMDI is the result of a multi-year development effort between Cohero Health and Presspart. The relationship has resulted in production of functional devices, now readily available to the
Read More
Mobile Spirometer Provider Cohero Health Raises $2M
Cohero Health, an NYC-based digital health company focused on developing connected health tools and technologies to improve respiratory care, has raised $2 million in seed funding. Key investors in the seed round include Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts, Three Leaf Ventures an affiliate of the Broe Group, Bioadvance, Swanhill Capital and StartUp Health. The company plans to use the funding to scale production of its devices to support large
Read More
Cohero Health’s Mobile Spirometer Receives FDA Clearance
Cohero Health, an NYC-based digital health company focused on developing connected health tools and technologies to improve respiratory care, has received 510(k) clearance from the FDA for its mobile spirometer. The handheld, wireless spirometer measures critical lung function metrics with the same precision as clinical-grade spirometers. The mobile spirometer pairs with a smartphone or tablet, enabling real-time measurement and reporting.
The device integrates with Cohero Health’s mobile
Read More
